GST on occlusion devices under Schedule remains taxable, with the applicable rate effective until the specified cutoff date. Patent Ductus Arteriosus and Atrial Septal Defect occlusion devices classifiable under Chapter 90 or any other chapter are treated as goods under Schedule 2 and attract the Schedule 2 GST rate; this schedule-based tariff treatment applies up to 21-09-2025.